Past two years Past Year Past 30 Days
Abstract Views 228 81 2
Full Text Views 3 1 0
PDF Downloads 1 1 0
 
 
 
 
 
 
 
 
 
 
 

In Vitro Susceptibility of Plasmodium falciparum Isolates from Jilore, Kenya, to Antimalarial Drugs

William M. Watkins

Search for other papers by William M. Watkins in
Current site
Google Scholar
PubMed
Close
,
Robert E. HowellsDepartment of Parasitology, Liverpool School of Tropical Medicine, Liverpool, England

Search for other papers by Robert E. Howells in
Current site
Google Scholar
PubMed
Close
,
A. David Brandling-Bennett

Search for other papers by A. David Brandling-Bennett in
Current site
Google Scholar
PubMed
Close
, and
David K. KoechBiomedical Sciences Research Centre, Kenya Medical Research Institute, Nairobi, Kenya

Search for other papers by David K. Koech in
Current site
Google Scholar
PubMed
Close
View More View Less
Restricted access

Twenty-six Plasmodium falciparum isolates obtained during a prophylaxis study at Jilore primary school, Malindi, Kenya, were adapted to in vitro culture and their susceptibility to 13 antimalarial drugs was tested by a modified radioisotopic method. Pyrimethamine, chloroquine, amodiaquine, cycloguanil, chlorcycloguanil, quinine, quinidine and sulfadoxine, and the experimental compounds MB 35769, mefloquine, WR 184806, parvoquone, and menoctone were used. The isolates could be divided into two groups with significantly different susceptibility to pyrimethamine, shown by a 755-fold difference in the mean ID50 values (2.77 ± 1.98 × 10-10 mol/l and 2.09 ± 1.64 × 10-7 mol/l). The mean susceptibility of the two groups differed 7.7-fold for chlorcycloguanil and 14.6-fold for cycloguanil, but were not significantly different for the other drugs. All isolates were more sensitive to amodiaquine than to chloroquine in vitro. The ratio of the geometric mean ID50 values of chloroquine to amodiaquine was 3.13. The ratio for the chemically related compounds parvoquone to menoctone was 5.63, quinine to quinidine was 5.58, and mefloquine to WR 184806 was 12.16.

Save